Kurs & Likviditet
Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Today, Paxman publishes the December issue of its newsletter aimed at shareholders, investors and other interested parties.
This month’s issue highlights Paxman’s directed share issue of 1,400,000 shares to existing and new shareholders, including including Creades AB (publ), Alcur Fonder and Andra AP-fonden. The proceeds from the share issue will be used to to strengthen the company’s financial position and the continued work to execute on its commercialisation strategy, including the launch of a new buy-and-bill business model in the United States to enable reimbursement.
The newsletter also includes information on "Knowledge Transfer Partnership” (KPT), a new collaboration between Paxman and the University of Huddersfield to develop a novel medical device for the prevention of chemotherapy-induced peripheral neuropathy (CIPN) with financing from Innovate UK, several received orders for upgrades and new installations in the US, Europe, Asia and the Middle East, and that Paxman Scalp Cooling has been included in the new generation of an innovative mobile cancer care concept developed by the British charity Hope for Tomorrow.
To read the newsletter and subscribe for upcoming issues, follow this link:
https://bit.ly/paxdec21en
Paxman’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on Paxman’s website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.